Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Front Mol Neurosci ; 13: 82, 2020.
Article in English | MEDLINE | ID: mdl-32508591

ABSTRACT

In utero electroporation (IUE) is a powerful tool for testing the role of genes in neuronal migration and function, but this technique suffers from high degrees of variability. Such variability can result from inconsistent surgery, developmental gradients along both rostral-caudal and medial-lateral axes, differences within littermates and from one litter to another. Comparisons between control and experimental electroporations rely on section matching, which is inherently subjective. These sources of variability are cumulative, leading to difficult to interpret data and an increased risk of both false positives and false negatives. To address these limitations, we developed two tools: (1) a new plasmid, termed Double UP, which combines LoxP-flanked reporters and limiting Cre dosages to generate internal controls, and (2) an automated program for unbiased and precise quantification of migration. In concert, these tools allow for more rigorous and objective experiments, while decreasing the mice, time, and reagents required to complete studies.

2.
Life Sci Alliance ; 2(3)2019 06.
Article in English | MEDLINE | ID: mdl-31160379

ABSTRACT

The F-BAR family of proteins play important roles in many cellular processes by regulating both membrane and actin dynamics. The CIP4 family of F-BAR proteins is widely recognized to function in endocytosis by elongating endocytosing vesicles. However, in primary cortical neurons, CIP4 concentrates at the tips of extending lamellipodia and filopodia and inhibits neurite outgrowth. Here, we report that the highly homologous CIP4 family member, FBP17, induces tubular structures in primary cortical neurons and results in precocious neurite formation. Through domain swapping and deletion experiments, we demonstrate that a novel polybasic region between the F-BAR and HR1 domains is required for membrane bending. Moreover, the presence of a poly-PxxP region in longer splice isoforms of CIP4 and FBP17 largely reverses the localization and function of these proteins. Thus, CIP4 and FBP17 function as an antagonistic pair to fine-tune membrane protrusion, endocytosis, and neurite formation during early neuronal development.


Subject(s)
Cell Surface Extensions/metabolism , Microtubules/metabolism , Nerve Tissue Proteins/metabolism , Neuronal Outgrowth , Neurons/physiology , Amino Acid Sequence , Animals , Biomarkers , Cell Line , Cell Membrane/metabolism , Cerebral Cortex/cytology , Cerebral Cortex/metabolism , Gene Expression , Humans , Immunohistochemistry , Mice , Models, Biological , Molecular Imaging , Multigene Family , Mutation , Nerve Tissue Proteins/chemistry , Nerve Tissue Proteins/genetics , Protein Binding , Protein Transport
3.
Sci Rep ; 8(1): 13194, 2018 09 04.
Article in English | MEDLINE | ID: mdl-30181589

ABSTRACT

Dielectrophoresis using multi-electrode arrays allows a non-invasive interface with biological cells for long-term monitoring of electrophysiological parameters as well as a label-free and non-destructive technique for neuronal cell manipulation. However, experiments for neuronal cell manipulation utilizing dielectrophoresis have been constrained because dielectrophoresis devices generally function outside of the controlled environment (i.e. incubator) during the cell manipulation process, which is problematic because neurons are highly susceptible to the properties of the physiochemical environment. Furthermore, the conventional multi-electrode arrays designed to generate dielectrophoretic force are often fabricated with non-transparent materials that confound live-cell imaging. Here we present an advanced single-neuronal cell culture and monitoring platform using a fully transparent microfluidic dielectrophoresis device for the unabated monitoring of neuronal cell development and function. The device is mounted inside a sealed incubation chamber to ensure improved homeostatic conditions and reduced contamination risk. Consequently, we successfully trap and culture single neurons on a desired location and monitor their growth process over a week. The proposed single-neuronal cell culture and monitoring platform not only has significant potential to realize an in vitro ordered neuronal network, but also offers a useful tool for a wide range of neurological research and electrophysiological studies of neuronal networks.


Subject(s)
Cell Culture Techniques/instrumentation , Lab-On-A-Chip Devices , Neurons/cytology , Single-Cell Analysis/instrumentation , Animals , Cells, Cultured , Equipment Design , Microfluidic Analytical Techniques/instrumentation , Optical Imaging/instrumentation , Rats, Sprague-Dawley
4.
Dev Neurobiol ; 76(12): 1293-1307, 2016 12.
Article in English | MEDLINE | ID: mdl-27112549

ABSTRACT

The generation of axon collateral branches is a fundamental aspect of the development of the nervous system and the response of axons to injury. Although much has been discovered about the signaling pathways and cytoskeletal dynamics underlying branching, additional aspects of the cell biology of axon branching have received less attention. This review summarizes recent advances in our understanding of key factors involved in axon branching. This article focuses on how cytoskeletal mechanisms, intracellular organelles, such as mitochondria and the endoplasmic reticulum, and membrane remodeling (exocytosis and endocytosis) contribute to branch initiation and formation. Together this growing literature provides valuable insight as well as a platform for continued investigation into how multiple aspects of axonal cell biology are spatially and temporally orchestrated to give rise to axon branches. © 2016 Wiley Periodicals, Inc. Develop Neurobiol 76: 1293-1307, 2016.


Subject(s)
Axons/metabolism , Cytoskeleton/metabolism , Growth Cones/metabolism , Microtubules/metabolism , Organelles/metabolism , Animals , Humans , Neurogenesis/physiology
5.
J Cell Sci ; 129(1): 166-77, 2016 Jan 01.
Article in English | MEDLINE | ID: mdl-26567222

ABSTRACT

Nervous wreck (Nwk) is a conserved F-BAR protein that attenuates synaptic growth and promotes synaptic function in Drosophila. In an effort to understand how Nwk carries out its dual roles, we isolated interacting proteins using mass spectrometry. We report a conserved interaction between Nwk proteins and BAR-SH3 sorting nexins, a family of membrane-binding proteins implicated in diverse intracellular trafficking processes. In mammalian cells, BAR-SH3 sorting nexins induce plasma membrane tubules that localize NWK2, consistent with a possible functional interaction during the early stages of endocytic trafficking. To study the role of BAR-SH3 sorting nexins in vivo, we took advantage of the lack of genetic redundancy in Drosophila and employed CRISPR-based genome engineering to generate null and endogenously tagged alleles of SH3PX1. SH3PX1 localizes to neuromuscular junctions where it regulates synaptic ultrastructure, but not synapse number. Consistently, neurotransmitter release was significantly diminished in SH3PX1 mutants. Double-mutant and tissue-specific-rescue experiments indicate that SH3PX1 promotes neurotransmitter release presynaptically, at least in part through functional interactions with Nwk, and might act to distinguish the roles of Nwk in regulating synaptic growth and function.


Subject(s)
Conserved Sequence , Drosophila Proteins/metabolism , Drosophila melanogaster/metabolism , Nerve Tissue Proteins/metabolism , Sorting Nexins/metabolism , Synapses/metabolism , Synaptic Transmission , Animals , Carrier Proteins/metabolism , Cell Line , Cerebral Cortex/cytology , Intracellular Signaling Peptides and Proteins , Mice , Mutation/genetics , Neurogenesis , Neuromuscular Junction/metabolism , Neurons/metabolism , Neurotransmitter Agents/metabolism , Protein Binding , Protein Transport , Synapses/ultrastructure
6.
J Surg Res ; 195(2): 588-95, 2015 May 15.
Article in English | MEDLINE | ID: mdl-25772147

ABSTRACT

BACKGROUND: Endoplasmic reticulum (ER) stress and autophagy each play important roles in hepatocyte cell injury. We hypothesized that gene expression of C/EBP-homologous protein (CHOP) and the BH3 proteins Bcl2-interacting mediator of cell death (BIM) and BH3-interacting domain death agonist (BID) are involved in a complex interplay that regulates ER stress-induced autophagy and cell death. MATERIALS AND METHODS: Hepatocytes were cultured from lean Zucker rats. Confluent hepatocytes were incubated with single or combined small interfering RNA for CHOP, BIM, and/or BID for 24 h providing gene inhibition. Incubation with tunicamycin (TM) for another 24 h stimulated ER stress. Quantitative real-time polymerase chain reaction determined the expression levels of CHOP, BIM, and BID. Immunostaining with microtubule-associated protein 1 light chain 3 measured autophagy activity. Trypan blue exclusion determined the cell viability. RESULTS: TM treatment increased the messenger RNA levels of CHOP and BIM but decreased the messenger RNA levels of BID. TM increased autophagy and decreased cell viability. Individual inhibition of CHOP, BIM, or BID protected against autophagy and cell death. However, simultaneous treatment with any combination of CHOP, BIM, and BID small interfering RNAs reduced autophagy activity but increased cell death independent of ER stress induction. CONCLUSIONS: Autophagy in hepatocytes results from acute ER stress and involves interplay, at the gene expression level, of CHOP, BIM, and BID. Inhibition of any one of these individual genes during acute ER stress is protective against cell death. Conversely, inhibition of any two of the three genes results in increased nonautophagic cell death independent of ER stress induction. This study suggests interplay between CHOP, BIM, and BID expression that can be leveraged for protection against ER stress-related cell death. However, disruption of the CHOP/BH3 gene expression homeostasis is detrimental to cell survival independent of other cellular stress.


Subject(s)
Apoptosis Regulatory Proteins/physiology , Autophagy/physiology , BH3 Interacting Domain Death Agonist Protein/physiology , Hepatocytes/physiology , Membrane Proteins/physiology , Proto-Oncogene Proteins/physiology , Transcription Factor CHOP/physiology , Animals , Apoptosis Regulatory Proteins/genetics , BH3 Interacting Domain Death Agonist Protein/genetics , Bcl-2-Like Protein 11 , Cells, Cultured , Endoplasmic Reticulum Stress , Gene Expression Regulation , Male , Membrane Proteins/genetics , Proto-Oncogene Proteins/genetics , RNA, Small Interfering/genetics , Rats , Rats, Zucker , Transcription Factor CHOP/genetics
7.
Drug Chem Toxicol ; 37(3): 357-64, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24328849

ABSTRACT

Bacopa monniera is a rejuvenating herb for brain cells enhancing learning and cognitive ability. In the present investigation, the ameliorative effects of Bacopa monniera were examined against lead-induced oxidative stress in different regions of rat brain. Male rats were divided into five groups: control (1000 ppm sodium acetate) and exposed (1000 ppm lead acetate) for 4 weeks; DMSA (Meso-2,3-Dimercaptosuccinic acid)-treated (90 mg/kg body weight/day); Bacopa monniera-treated (BM) (10 mg/kg body weight/day) and a combination of BM + DMSA for seven consecutive days after 4 weeks of lead exposure. After treatment, the whole brain was isolated by sacrificing rats and four regions were separated namely cerebellum, hippocampus, frontal cortex and brain stem. Results indicated a significant (p < 0.05) increase in reactive oxygen species (ROS), lipid peroxidation products (LPP) and total protein carbonyl content (TPCC) in association with tissue metal content in all the four regions of brain for exposed group compared with their respective controls. However, the lead-induced ROS, LPP, TPCC and tissue metal content were lowered on treatment with Bacopa monniera, almost reaching the control group values in all the above brain regions compared to DMSA and a combination therapy. Results suggest that Bacopa monniera can mitigate the lead induced-oxidative stress tissue specifically by pharmacologic interventions which encompass both chelation as well as antioxidant functions.


Subject(s)
Bacopa/chemistry , Organometallic Compounds/toxicity , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Animals , Antioxidants/pharmacology , Brain/drug effects , Brain/pathology , Lipid Peroxidation/drug effects , Male , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism
8.
J Cell Sci ; 126(Pt 11): 2411-23, 2013 Jun 01.
Article in English | MEDLINE | ID: mdl-23572514

ABSTRACT

Cdc42-interacting protein 4 (CIP4), a member of the F-BAR family of proteins, plays important roles in a variety of cellular events by regulating both membrane and actin dynamics. In many cell types, CIP4 functions in vesicle formation, endocytosis and membrane tubulation. However, recent data indicate that CIP4 is also involved in protrusion in some cell types, including cancer cells (lamellipodia and invadopodia) and neurons (ribbed lamellipodia and veils). In neurons, CIP4 localizes specifically to extending protrusions and functions to limit neurite outgrowth early in development. The mechanism by which CIP4 localizes to the protruding edge membrane and induces lamellipodial/veil protrusion and actin rib formation is not known. Here, we show that CIP4 localization to the protruding edge of neurons is dependent on both the phospholipid content of the plasma membrane and the underlying organization of actin filaments. Inhibiting phosphatidylinositol (3,4,5)-trisphosphate (PIP3) production decreases CIP4 at the membrane. CIP4 localization to the protruding edge is also dependent on Rac1/WAVE1, rather than Cdc42/N-WASP. Capping actin filaments with low concentrations of cytochalasin D or by overexpressing capping protein dramatically decreases CIP4 at the protruding edge, whereas inactivating Arp2/3 drives CIP4 to the protruding edge. We also demonstrate that CIP4 dynamically colocalizes with Ena/VASP and DAAM1, two proteins known to induce unbranched actin filament arrays and play important roles in neuronal development. Together, this is the first study to show that the localization of an F-BAR protein depends on both actin filament architecture and phospholipids at the protruding edge of developing neurons.


Subject(s)
Actin Cytoskeleton/metabolism , Cell Membrane/metabolism , Microtubule-Associated Proteins/metabolism , Neurites/metabolism , Actin-Related Protein 2-3 Complex/metabolism , Animals , Cell Adhesion Molecules/genetics , Cell Adhesion Molecules/metabolism , Cells, Cultured , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Mice , Microfilament Proteins/genetics , Microfilament Proteins/metabolism , Minor Histocompatibility Antigens , Neuropeptides/metabolism , Phospholipids/metabolism , Phosphoproteins/genetics , Phosphoproteins/metabolism , Protein Transport/physiology , Wiskott-Aldrich Syndrome Protein Family/metabolism , Wiskott-Aldrich Syndrome Protein, Neuronal/metabolism , cdc42 GTP-Binding Protein/metabolism , rac1 GTP-Binding Protein/metabolism , rho GTP-Binding Proteins/genetics , rho GTP-Binding Proteins/metabolism
9.
PLoS One ; 8(1): e53453, 2013.
Article in English | MEDLINE | ID: mdl-23308225

ABSTRACT

Catalytically defective rare variants of Sialic acid Acetyl Esterase (SIAE) have previously been linked to autoimmunity. Studies presented here confirm that the M89V SIAE protein and all other products of common variant alleles of SIAE are catalytically normal. Although overexpressing transfected non-lymphoid cells secrete small amounts of SIAE that can associate with the cell surface, normal human lymphocytes do not exhibit cell surface SIAE, supporting genetic evidence in mice that indicates that this protein functions in a lymphocyte intrinsic manner. Analyses of the plasma proteome also indicate that SIAE is not secreted in vivo. A re-analysis exclusively of catalytically defective rare variant alleles of SIAE in subjects in which this gene was completely sequenced confirmed an association of SIAE with autoimmunity. A subset of catalytically defective rare variant SIAE alleles has previously been typed in a large genotyping study comparing a diverse group of disease subjects and controls; our re-analysis of this data shows that catalytically defective alleles are enriched in disease subjects. These data suggest that SIAE may be associated with autoimmunity and that further study of catalytically defective rare variant SIAE alleles in terms of autoimmune disease susceptibility is strongly warranted.


Subject(s)
Acetylesterase/genetics , Autoimmune Diseases/genetics , Autoimmunity , Mutation , Polymorphism, Single Nucleotide , Acetylesterase/metabolism , Alleles , Animals , Autoimmune Diseases/enzymology , Biocatalysis , Enzyme Assays , Gene Expression , Gene Frequency , Genetic Predisposition to Disease , Genotype , HEK293 Cells , Humans , Mice
10.
Nature ; 466(7303): 243-7, 2010 Jul 08.
Article in English | MEDLINE | ID: mdl-20555325

ABSTRACT

Sialic acid acetylesterase (SIAE) is an enzyme that negatively regulates B lymphocyte antigen receptor signalling and is required for the maintenance of immunological tolerance in mice. Heterozygous loss-of-function germline rare variants and a homozygous defective polymorphic variant of SIAE were identified in 24/923 subjects of European origin with relatively common autoimmune disorders and in 2/648 controls of European origin. All heterozygous loss-of-function SIAE mutations tested were capable of functioning in a dominant negative manner. A homozygous secretion-defective polymorphic variant of SIAE was catalytically active, lacked the ability to function in a dominant negative manner, and was seen in eight autoimmune subjects but in no control subjects. The odds ratio for inheriting defective SIAE alleles was 8.6 in all autoimmune subjects, 8.3 in subjects with rheumatoid arthritis, and 7.9 in subjects with type I diabetes. Functionally defective SIAE rare and polymorphic variants represent a strong genetic link to susceptibility in relatively common human autoimmune disorders.


Subject(s)
Acetylesterase/genetics , Autoimmune Diseases/enzymology , Autoimmune Diseases/genetics , Autoimmunity/genetics , Carboxylic Ester Hydrolases/genetics , Genetic Predisposition to Disease/genetics , Germ-Line Mutation/genetics , N-Acetylneuraminic Acid/metabolism , Acetylation , Acetylesterase/metabolism , Alleles , Animals , Antibodies, Antinuclear/blood , Arthritis, Rheumatoid/enzymology , Arthritis, Rheumatoid/genetics , B-Lymphocytes/metabolism , Biocatalysis , Carboxylic Ester Hydrolases/metabolism , Case-Control Studies , Cell Line , Diabetes Mellitus, Type 1/enzymology , Diabetes Mellitus, Type 1/genetics , Europe/ethnology , Exons/genetics , Humans , Mice , Odds Ratio , Polymorphism, Single Nucleotide/genetics , Sample Size , Sequence Analysis, DNA
11.
J Thorac Cardiovasc Surg ; 135(5): 1014-21, 2008 May.
Article in English | MEDLINE | ID: mdl-18455578

ABSTRACT

OBJECTIVES: Lung cancer is associated with a significant rate of locoregional recurrence after surgical resection, particularly when nonanatomic wedge resections are performed. The primary aim of this study was to assess the feasibility of a microsphere drug delivery system to locally deliver chemotherapy and prevent the establishment and growth of lung cancer cells and establish proof of concept for a potential future approach to target occult microscopic disease remaining at the surgical resection margin. METHODS: Poly-(D,L-lactic-co-glycolic acid) (PLGA) microspheres loaded with the antineoplastic agent paclitaxel were prepared and tested for antitumor efficacy in an in vitro cell proliferation assay for tumor inhibition and induction of apoptosis. The in vivo prevention of Lewis lung carcinoma cell establishment and growth in subcutaneous tissues of mice was also assessed by comparing 4 treatment groups: Lewis lung carcinoma cells alone, Lewis lung carcinoma cells combined with 100 x 10(6) unloaded (carrier alone) PLGA microspheres, and Lewis lung carcinoma cells combined with 50 x 10(6) or 100 x 10(6) paclitaxel-loaded PLGA microspheres. After the coinjection of Lewis lung carcinoma cells with or without microspheres, in vivo tumor growth was monitored, and tumor weight was recorded on death. RESULTS: Paclitaxel-loaded PLGA microspheres were found to effectively prevent growth of tumor cells in culture through the induction of apoptosis. Similarly, paclitaxel-loaded PLGA microspheres significantly inhibited tumor growth in vivo at both the 50 x 10(6) and 100 x 10(6) microsphere dose (0.497 +/- 0.183 and 0.187 +/- 0.083 g total tumor weight, respectively) compared with 2.91 +/- 0.411 g for Lewis lung carcinoma cells with unloaded microspheres and 3.37 +/- 0.433 g for untreated tumor (P < .001). Toxicity was not clinically apparent in any animal treated with paclitaxel-loaded PLGA microspheres. CONCLUSIONS: Paclitaxel-loaded PLGA microspheres induce tumor apoptosis and inhibit the establishment and growth of lung cancer cells both in vitro and in vivo without obvious systemic toxicity. By using models consistent with localized microscopic tumor burdens, these results suggest that local delivery of paclitaxel through a microsphere system might lead to an effective future method of decreasing local tumor recurrence in non-small cell lung cancer when applied to the surgical margins at risk for microscopic tumor foci. Such an approach might be particularly efficacious after wedge resection in the setting of poor pulmonary reserve or significant comorbidity, where local recurrence rates are increased and acceptable alternative treatment options are limited.


Subject(s)
Antineoplastic Agents, Phytogenic/administration & dosage , Lung Neoplasms/prevention & control , Neoplasm Recurrence, Local/prevention & control , Paclitaxel/administration & dosage , Animals , Apoptosis/drug effects , Cell Line, Tumor , Feasibility Studies , Female , Mice , Mice, Inbred C57BL , Microspheres
12.
Cell Immunol ; 251(1): 43-9, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18457820

ABSTRACT

Facilitating cells (FC) are bone marrow-derived cells that facilitate allogeneic hematopoietic stem cell (SC) engraftment and induce transplantation tolerance without causing graft vs. host disease. Although there is evidence for FC directing the development of FoxP3+CD4+CD25+ regulatory T cells, the specific FC subsets that control regulatory T cell development have not been defined. The current study investigates the role of FC-CD3epsilon+ and FC-CD3epsilon- subpopulations in the development of FoxP3+CD4+CD25+ regulatory T cells. Here, we demonstrate that the induction of FoxP3+CD4+CD25+ regulatory T cells in coculture is mediated by not only the FC-CD3epsilon- subset but also the FC-CD3epsilon+ subset, which is distinct from plasmacytoid precursor dendritic cells (p-preDC). The identification of cell populations distinct from p-preDC that efficiently induce the generation of FoxP3+CD4+CD25+ regulatory T cells may prove useful for future therapeutic applications for the induction of tolerance following allogeneic SC transplantation.


Subject(s)
Bone Marrow Cells/immunology , Dendritic Cells/immunology , Forkhead Transcription Factors/biosynthesis , Interleukin-2 Receptor alpha Subunit/biosynthesis , T-Lymphocytes, Regulatory/immunology , Animals , Bone Marrow Cells/cytology , CD4 Antigens/biosynthesis , Cell Differentiation/immunology , Cells, Cultured , Coculture Techniques , Cytokines/biosynthesis , Cytokines/genetics , Female , Gene Expression/immunology , Genes, T-Cell Receptor beta , Interferon-gamma/biosynthesis , Interferon-gamma/genetics , Mice , Mice, Inbred C57BL , RNA, Messenger/biosynthesis , T-Lymphocyte Subsets/immunology , T-Lymphocytes, Regulatory/cytology , Toll-Like Receptor 9/biosynthesis , Toll-Like Receptor 9/genetics , Transforming Growth Factor beta/biosynthesis , Transforming Growth Factor beta/genetics
13.
J Immunol ; 179(4): 2153-62, 2007 Aug 15.
Article in English | MEDLINE | ID: mdl-17675474

ABSTRACT

The establishment of donor cell lineages following allogeneic bone marrow transplantation is frequently associated with the development of graft-vs-host disease (GVHD). The identification of cell populations that are capable of supporting allogeneic stem cell (SC) engraftment and the induction of tolerance without inducing GVHD could expand the use of this therapy. CD8(+)TCR(-) facilitating cells (FC) have been shown to promote allogeneic SC engraftment with resulting transplantation tolerance across complete MHC barriers without inducing GVHD. Although donor reconstitution in SC plus FC recipients is associated with the induction of regulatory T cell-associated factors, it is not known whether an induction of regulatory T cells and subsequent tolerance is a direct effect of the FC. The current study demonstrates that 1) SC plus FC transplantation results in the induction of donor CD4(+)25(+) regulatory T cells and that FC are present in the spleen of recipients before the induction of these cells, 2) activation of FC with CpG-oligodeoxynucleotide promotes CD4(+)25(-) T cell differentiation into CD4(+)25(+) regulatory T cells in vitro, as demonstrated by cytokine and forkhead/winged helix transcription factor (FoxP3) gene and protein expression, and 3) direct contact between FC and CD4(+)25(-) T cells is required for FoxP3(+)CD4(+)25(+) regulatory T cell induction and is dependent on CD86 expression on FC. This is the first report to demonstrate a mechanism for FC in the induction of regulatory T cells following allogeneic SC plus FC transplantation. The transplantation of donor FC may provide an alternative approach to permit clinical SC engraftment and induction of transplantation tolerance in the future.


Subject(s)
Bone Marrow Cells/immunology , Forkhead Transcription Factors/immunology , Graft Survival/immunology , Hematopoietic Stem Cell Transplantation , T-Lymphocytes, Regulatory/immunology , Transplantation Tolerance/immunology , Animals , B7-2 Antigen/immunology , B7-2 Antigen/metabolism , Bone Marrow Cells/metabolism , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Cell Differentiation/drug effects , Cell Differentiation/immunology , Cytokines/immunology , Cytokines/metabolism , Female , Forkhead Transcription Factors/biosynthesis , Gene Expression Regulation/drug effects , Gene Expression Regulation/immunology , Graft vs Host Disease/immunology , Graft vs Host Disease/metabolism , Mice , Oligonucleotides/pharmacology , T-Lymphocytes, Regulatory/metabolism , Transplantation Tolerance/drug effects , Transplantation, Homologous
14.
J Immunol ; 177(3): 1444-50, 2006 Aug 01.
Article in English | MEDLINE | ID: mdl-16849450

ABSTRACT

Transplantation of purified allogeneic hemopoietic stem cells (SC) alone is characterized by a decreased risk of graft-vs-host disease but increased incidence of engraftment failure. It has been established that the facilitating cell (FC) promotes allogeneic SC reconstitution and results in donor-specific transplantation tolerance across MHC disparities, without graft-vs-host disease. Although the requirements for this facilitating function are not well-characterized, it is known that facilitation is dependent on FC expression of a unique heterodimer consisting of the TCR beta-chain (TCRbeta) and a 33-kDa protein, FCp33. The current study confirms that CD3epsilon and TCRbeta expression are present on the FC at the time of transplantation and demonstrates that the majority of cells in the FC population express the TCR signaling molecule, FcRgamma, rather than the more conventional CD3zeta receptor. Of particular significance, we have now demonstrated that FC-mediated allogeneic SC reconstitution is critically dependent on FcRgamma expression and that FcRgamma coprecipitates with the TCRbeta-FCp33 heterodimer. The mandatory requirement of TCRbeta and FcRgamma for FC function provides the first evidence of a previously undescribed role for FcRgamma in the facilitation of allogeneic SC reconstitution and establishes that FcRgamma is part of the TCRbeta-FCp33 complex uniquely expressed on FC.


Subject(s)
Bone Marrow Transplantation/immunology , Carrier Proteins/physiology , Hematopoietic Stem Cell Transplantation , Isoantigens/metabolism , Receptors, Antigen, T-Cell, alpha-beta/physiology , Receptors, IgG/physiology , Animals , CD3 Complex/biosynthesis , CD3 Complex/genetics , CD3 Complex/physiology , Dimerization , Female , Hematopoietic Stem Cells/immunology , Hematopoietic Stem Cells/metabolism , Immunophenotyping , Isoantigens/biosynthesis , Mice , Mice, Inbred C57BL , Mice, Knockout , Receptors, Antigen, T-Cell, alpha-beta/biosynthesis , Receptors, Antigen, T-Cell, alpha-beta/metabolism , Receptors, IgG/biosynthesis , Receptors, IgG/metabolism , Transcription, Genetic
15.
Blood ; 104(12): 3829-35, 2004 Dec 01.
Article in English | MEDLINE | ID: mdl-15297318

ABSTRACT

Graft-versus-host disease (GVHD) and failure of engraftment limit clinical bone marrow transplantation (BMT) to patients with closely matched donors. Engraftment failure of purified allogeneic hematopoietic stem cells (HSCs) has been decreased in various BMT models by including donor BM-derived CD8(+)/alphabetagammadeltaTCR(-) facilitating cells (FCs) or CD8(+)/alphabetaTCR(+) T cells in the BM inoculum. To aggressively investigate the GVHD potential of these donor CD8(+) populations, a purified cell model of lethal GVHD was established in a murine semiallogeneic parent --> F(1) combination. Lethally irradiated recipients were reconstituted with purified donor HSCs alone or in combination with splenic T cells (T(SP)), BM-derived T cells (T(BM)), or the FC population. In marked contrast to the lethal GVHD present in recipients of HSCs plus T(SP) or CD8(+) T(BM), recipients of donor HSC+FC inocula did not exhibit significant clinical or histologic evidence of GVHD. Instead, HSC+FC recipients were characterized by increased splenocyte expression of transforming growth factor-beta (TGF-beta) and the induction of the regulatory T-cell genes CTLA4, GITR, and FoxP3. These findings suggest that the FCs, which express a unique FCp33-TCRbeta heterodimer in place of alphabetaTCR, permits HSC alloengraftment and prevents GVHD through the novel approach of regulatory T-cell induction in vivo.


Subject(s)
Graft Survival/immunology , Graft vs Host Disease/etiology , Hematopoietic Stem Cell Transplantation/methods , T-Lymphocytes/transplantation , Animals , Antigens, CD , Antigens, Differentiation/genetics , CD8-Positive T-Lymphocytes/pathology , CD8-Positive T-Lymphocytes/transplantation , CTLA-4 Antigen , DNA-Binding Proteins/genetics , Forkhead Transcription Factors , Gene Expression Regulation , Glucocorticoid-Induced TNFR-Related Protein , Graft vs Host Disease/immunology , Hematopoietic Stem Cell Transplantation/adverse effects , Lymphocyte Transfusion , Mice , Mice, Inbred Strains , Receptors, Nerve Growth Factor/genetics , Receptors, Tumor Necrosis Factor/genetics , Spleen/metabolism , T-Lymphocyte Subsets/metabolism , T-Lymphocyte Subsets/physiology , T-Lymphocyte Subsets/transplantation , T-Lymphocytes/metabolism , T-Lymphocytes/physiology , Transforming Growth Factor beta/genetics , Transplantation, Homologous
SELECTION OF CITATIONS
SEARCH DETAIL
...